Hedia Raises €3M Seed Extension to Expand Digital Health Portfolio

This exciting news follows the update earlier this week, where Hedia announced their new CEO, Lars Lund. This exciting news follows the update earlier this week, where Hedia announced their new CEO,Lars Lund. Today,Lars Christian Lundsaid about the financial extension, " As I take the reins in Hedia, I am delighted to see the confidence from our investors in our world class team, our existing groundbreaking technology as well as our strong pipeline.  Hedia will now be able to build on...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

This exciting news follows the update earlier this week, where Hedia announced their new CEO, Lars Lund.

Today, Lars Christian Lund said about the financial extension, "As I take the reins in Hedia, I am delighted to see the confidence from our investors in our world class team, our existing groundbreaking technology as well as our strong pipeline.  Hedia will now be able to build on our existing momentum and accelerate the commercialization of our solutions making life with diabetes easier."

Hedia.com – LinkedIn – Facebook

About Hedia

Hedia is a leading digital therapeutics company within diabetes, committed to help people with insulin-dependent diabetes gain control of their condition.  Making life with diabetes easier has been the incentive from the beginning of building Hedia Diabetes Assistant and the solution is today available in 11 countries. Based on habits of the individual person with diabetes and personalized input, our diabetes app generates insulin recommendations by taking many aspects of diabetes management into account – such as recording blood glucose readings, keeping track of active insulin, measuring carbs, calculating an insulin dosage, keeping track of activity and recording blood ketones.

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/hedia-raises-3m-seed-extension-to-expand-digital-health-portfolio-302072595.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;